LSPN Europe 2025

The 2025 LSPN Europe Conference took place on 4 November in London, bringing together senior IP professionals from the pharmaceutical, biotechnology and medtech sectors. 

The event provided a platform for sharing insights, exploring emerging trends, and discussing the practical challenges of managing intellectual property throughout a product’s life cycle.

The programme was carefully curated to balance expert presentations, panel discussions and interactive roundtables, allowing participants to learn from peers, gain diverse perspectives, and engage in informal networking. This structure ensures attendees leave with practical knowledge and meaningful professional connections.

Over half of the audience consisted of in-house professionals from pharma, biotech and medtech companies, creating the ideal environment for discussing the evolving IP landscape and strategies to protect, manage and monetise innovation.

Attending organisations included McDermott Will & Emery, Curevac, Regeneron, HGF, Unified Patent Court, Morgan Lewis, Centre for Advanced Studies in Bioscience Innovation Law, LCM Biosensor Technologies, Mewburn Ellis, Bicycle Therapeutics, RNA Law, Daniel IP, Astellas, BSKB, Ichnos Sciences, Kilburn & Strode, Zentiva, AstraZeneca, SNIPR Biome, DF MP, Autolus and Independent.